Zenas BioPharma, Inc.
(NASDAQ: ZBIO)

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

38.110

+1.440 (+3.93%)
Range 34.720 - 38.120   (9.79%)
Open 36.620
Previous Close 36.670
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 240,022
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis